Understanding how glioblastoma develops resistance to sophisticated two-pronged treatments like suicide gene therapy and EGFR inhibitors.
Explore how DNA methylation profiling is revolutionizing glioblastoma research and treatment through epigenetic analysis of glioma stem cells and extracellular vesicles.
Exploring how simultaneous inhibition of LSD1 and HDACs synergistically dismantles Glioblastoma's defenses through epigenetic reprogramming.
Discover how myeloid cells suppress immunity in glioblastomas through four distinct programs revealed by single-cell RNA sequencing.